Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report)'s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $161.77 and last traded at $161.77, with a volume of 865 shares changing hands. The stock had previously closed at $125.34.
Wall Street Analysts Forecast Growth
ADUS has been the topic of a number of research analyst reports. JMP Securities started coverage on shares of Addus HomeCare in a research report on Monday, December 16th. They issued an "outperform" rating and a $150.00 target price on the stock. Royal Bank of Canada restated an "outperform" rating and issued a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Citizens Jmp upgraded shares of Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. Macquarie reiterated an "outperform" rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Stephens upped their price target on Addus HomeCare from $143.00 to $145.00 and gave the company an "overweight" rating in a research report on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Addus HomeCare currently has an average rating of "Buy" and an average price target of $133.67.
View Our Latest Analysis on Addus HomeCare
Addus HomeCare Trading Up 0.8 %
The firm has a fifty day moving average of $125.02 and a 200 day moving average of $126.08. The company has a market capitalization of $2.29 billion, a P/E ratio of 28.91, a P/E/G ratio of 2.11 and a beta of 1.00.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business's quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.03 EPS. Sell-side analysts anticipate that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.
Insider Activity at Addus HomeCare
In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares of the company's stock, valued at $9,905,569.72. The trade was a 23.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares of the company's stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 39,750 shares of company stock worth $4,930,750. 4.60% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Addus HomeCare
A number of hedge funds have recently made changes to their positions in the stock. Texas Permanent School Fund Corp raised its stake in Addus HomeCare by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company's stock valued at $1,636,000 after buying an additional 82 shares during the last quarter. Arizona State Retirement System raised its position in shares of Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company's stock worth $527,000 after purchasing an additional 87 shares during the last quarter. Inspire Investing LLC increased its position in shares of Addus HomeCare by 3.3% during the third quarter. Inspire Investing LLC now owns 3,111 shares of the company's stock worth $414,000 after purchasing an additional 100 shares in the last quarter. New York State Teachers Retirement System raised its position in shares of Addus HomeCare by 1.2% in the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company's stock valued at $1,132,000 after buying an additional 100 shares during the last quarter. Finally, Equitable Trust Co. lifted its stake in Addus HomeCare by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 4,825 shares of the company's stock worth $642,000 after purchasing an additional 106 shares in the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
Addus HomeCare Company Profile
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.